Evidence map›Paper›PMID 30071087›Full record

ArticlePloS one2018

Improved glucose metabolism by Eragrostis tef potentially through beige adipocyte formation and attenuating adipose tissue inflammation.

Mengistu Lemecha, Katsutaro Morino, Daniel Seifu, Takeshi Imamura, Fumiyuki Nakagawa, Aki Nagata, Takuya Okamato, Osamu Sekine, Satoshi Ugi, Hiroshi Maegawa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nutritional Values of Teff (Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Mengistu LemechaDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Katsutaro MorinoDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.ORCID 0000-0003-2420-3817
Daniel SeifuSchool of Medicine, Department of Biochemistry, Addis Ababa University, Addis Ababa, Ethiopia.
Takeshi ImamuraDivision of Molecular Pharmacology, Faculty of Medicine, Tottori University, Yonago, Japan.
Fumiyuki NakagawaDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Aki NagataCMIC Pharma Science, Osaka, Japan.
Takuya OkamatoDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Osamu SekineDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Satoshi UgiDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Hiroshi MaegawaDivision of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Shiga University of Medical Science · JPAddis Ababa University · ETLTT Bio-Pharma (Japan) · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTeff is a staple food in Ethiopia that is rich in dietary fiber. Although gaining popularity in Western countries because it is gluten-free, the effects of teff on glucose metabolism remain unknown.

aimTo evaluate the effects of teff on body weight and glucose metabolism compared with an isocaloric diet containing wheat.

resultsMice fed teff weighed approximately 13% less than mice fed wheat (p < 0.05). The teff-based diet improved glucose tolerance compared with the wheat group with normal chow but not with a high-fat diet. Reduced adipose inflammation characterized by lower expression of TNFα, Mcp1, and CD11c, together with higher levels of cecal short chain fatty acids such as acetate, compared with the control diet containing wheat after 14 weeks of dietary treatment. In addition, beige adipocyte formation, characterized by increased expression of Ucp-1 (~7-fold) and Cidea (~3-fold), was observed in the teff groups compared with the wheat group. Moreover, a body-weight matched experiment revealed that teff improved glucose tolerance in a manner independent of body weight reduction after 6 weeks of dietary treatment. Enhanced beige adipocyte formation without improved adipose inflammation in a body-weight matched experiment suggests that the improved glucose metabolism was a consequence of beige adipocyte formation, but not solely through adipose inflammation. However, these differences between teff- and wheat-containing diets were not observed in the high-fat diet group.

conclusionsTeff improved glucose tolerance likely by promoting beige adipocyte formation and improved adipose inflammation.

Indexed as

Adipose Tissue, BeigeAnimalsApoptosis Regulatory ProteinsBlood GlucoseBody TemperatureCarbohydrate MetabolismCD11c AntigenDietary FiberEragrostisFatty Acids, VolatileFecesGlucose Tolerance TestInflammationMaleMiceMice, Inbred C57BLApoptosis Regulatory ProteinsBlood GlucoseCD11c AntigenCidea protein, mouseDietary FiberFatty Acids, VolatileTumor Necrosis Factor-alphaUncoupling Protein 1

Identifiers

PMID30071087
PMCPMC6072038
OpenAlexW2887633459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.